NCT06819852 · NOT YET RECRUITING

Acute Hospital Care at Home for People Living With Dementia

This trial tests whether people with moderate or severe dementia can receive acute hospital-level care at home instead of being admitted to an inpatient hospital. When they show up in the emergency department, enrolled patients are randomized to either home-based hospital care or standard inpatient care. It is a Phase NA trial, meaning this is a practical care-delivery study rather than a drug test — it is measuring whether the home model is safe and effective compared to usual care.

You may qualify if

  • Diagnosis of moderate or severe dementia (as ascertained by the Quick Dementia Rating System; QDRS)
  • Resides in a private or assisted living residence with or nearby (\<15min travel time) to a family caregiver
  • Resides within the Mass General Brigham (MGB) home hospital catchment area
  • Has had at least 1 hospitalization in the last 12 months.

You're excluded if

  • Hospitalized in the last 30 days
  • No functioning utilities, such as no working heat (October-April), no running water, or no electricity.
  • Resides in skilled nursing facility
  • Resides in group home
  • Domestic violence screen positive
  • In police custody
  • Family caregiver unable to initiate or maintain communication with care team
  • End-stage renal disease on hemodialysis
  • On methadone requiring daily pickup of medication
  • Active substance use disorder, without functioning treatment plan
  • Psychiatric diagnosis that would prohibit successful home hospital care
  • Acute delirium without explanation or without the ability to manage at home
  • Patients with cancer requiring consistent hospital-based treatments
  • Cannot ambulate to bedside commode with assistance present in the home (if different from baseline), unless home-based aides are available

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-08-12

View full record on ClinicalTrials.gov

All APOE4 clinical trials